Distribution date: 30 April 2004 | Final date for Comment: 20 April 2025

Products Covered: Drugs, quasi-drugs, cosmetics and medical devices (HS:30)

Regulation Type: Regular notification

Distribution date: 05 May 2004 | Final date for Comment: 20 April 2025

The Food and Drug Administration (FDA) is proposing to amend its regulations governing the format and content of labeling for human drug products for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 355). The proposed rule would require the addition of a statement that includes a toll-free number and advises that the number is to be used only for reporting side effects and is not intended for medical advice (the side effects statement). When finalized, this rule will bring FDA regulations into compliance with provisions of the Best Pharmaceuticals for Children Act (the BPCA).

Products Covered: Human Drug Products (HS Chapter  3003) (ICS 11.120)

Regulation Type: Regular notification

Distribution date: 05 May 2004 | Final date for Comment: 20 April 2025

The Food and Drug Administration (FDA) is proposing to amend its regulations governing the format and content of labeling for human drug products for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 355). The proposed rule would require the addition of a statement that includes a toll-free number and advises that the number is to be used only for reporting side effects and is not intended for medical advice (the side effects statement). When finalized, this rule will bring FDA regulations into compliance with provisions of the Best Pharmaceuticals for Children Act (the BPCA).

Products Covered: Human Drug Products (HS Chapter  3003) (ICS 11.120)

Regulation Type: Regular notification

Distribution date: 05 May 2004 | Final date for Comment: 20 April 2025

Establishment of maximum residue limits for veterinary drugs, Febantel, Fenbendazole and Oxfendazole, in foods.

Products Covered: Terrestrial mammals (muscle, fat, liver, kidney and other edible offal), poultry (muscle, liver and other edible offal), milk, globefish

Regulation Type: Regular notification

Distribution date: 05 May 2004 | Final date for Comment: 20 April 2025

Establishment of maximum residue limits for veterinary drugs, Febantel, Fenbendazole and Oxfendazole, in foods.

Products Covered: Terrestrial mammals (muscle, fat, liver, kidney and other edible offal), poultry (muscle, liver and other edible offal), milk, globefish

Regulation Type: Regular notification

Distribution date: 19 May 2004 | Final date for Comment: 20 April 2025

Amendments to the Regulations are proposed to establish safe limits for residues of the veterinary drugs ceftiofur, monensin, pirlimycin and teflubenzuron in foods originating from animals treated with these particular drugs. These veterinary drugs are an important tool in the production of healthy animals which are destined for use as food. Extensive studies have determined that the food commodities containing residues of ceftiofur, monensin, pirlimycin and teflubenzuron at levels up to the maximum residue limits (MRLs) listed in the proposed amendments are safe for consumption. These MRLs would apply to foods produced domestically or imported into Canada.

Products Covered: Veterinary drugs (ICS: 11.220)

Regulation Type: Regular notification

Distribution date: 19 May 2004 | Final date for Comment: 20 April 2025

Amendments to the Regulations are proposed to establish safe limits for residues of the veterinary drugs ceftiofur, monensin, pirlimycin and teflubenzuron in foods originating from animals treated with these particular drugs. These veterinary drugs are an important tool in the production of healthy animals which are destined for use as food. Extensive studies have determined that the food commodities containing residues of ceftiofur, monensin, pirlimycin and teflubenzuron at levels up to the maximum residue limits (MRLs) listed in the proposed amendments are safe for consumption. These MRLs would apply to foods produced domestically or imported into Canada.

Products Covered: Veterinary drugs (ICS: 11.220)

Regulation Type: Regular notification

Distribution date: 04 June 2004 | Final date for Comment: 20 April 2025

Define los parámetros y especificaciones de calidad de los cementos hidráulicos y de los componentes de éstos que normalmente se usan en el territorio nacional, sean producidos localmente o importados. Así como establecer la clasificación de dichos cementos por tipos, con sus respectivas especificaciones.

Products Covered: HS tariff item No. 2523.90.00.00

Regulation Type: Regular notification

Distribution date: 04 June 2004 | Final date for Comment: 20 April 2025

Define los parámetros y especificaciones de calidad de los cementos hidráulicos y de los componentes de éstos que normalmente se usan en el territorio nacional, sean producidos localmente o importados. Así como establecer la clasificación de dichos cementos por tipos, con sus respectivas especificaciones.

Products Covered: HS tariff item No. 2523.90.00.00

Regulation Type: Regular notification

Distribution date: 04 June 2004 | Final date for Comment: 20 April 2025

Define las características y especificaciones de calidad que deben cumplir los aceites vegetales comestibles incluidos, conservados mediante un tratamiento adecuado y destinados al consumo humano.

Products Covered: HS tariff headings 1507, 1508, 1511, 1512, 1513.29, 1514 and 1515

Regulation Type: Regular notification